Demo Sign up Log In

Enliven Therapeutics Inc (ELVN)

CapEx to Depreciation

14.14×

Quarterly · Period ending: Jun 30, 2026

ELVN CapEx to Depreciation

Latest reported14.14×period endingJun 30, 2026

Latest reported14.14×period endingJun 30, 2026

ELVN Quarterly CapEx/Depreciation (0.00× → 14.14×)

Latest values, visible window

High-resolution chart · PNG

ELVN capex to depreciation history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Enliven Therapeutics Inc CapEx to Depreciation — Quarterly
Period ending	CapEx to Depreciation
Jun 30, 2026	14.1429×
Mar 31, 2026	0×
Dec 31, 2025	0×
Sep 30, 2025	0.0161×
Jun 30, 2025	1.716×
Mar 31, 2025	0.2703×
Dec 31, 2024	0×
Sep 30, 2024	0.275×
Jun 30, 2024	0.0256×
Mar 31, 2024	0.2532×
Dec 31, 2023	0.1795×
Sep 30, 2023	0.2051×
Jun 30, 2023	1.1892×
Mar 31, 2023	0.4627×
Dec 31, 2022	1.5781×
Sep 30, 2022	0.2333×
Jun 30, 2022	5.8269×
Mar 31, 2022	4.9744×
Dec 31, 2021	0×
Sep 30, 2021	0×
Jun 30, 2021	0×
Mar 31, 2021	0.48×
Dec 31, 2020	0.1739×
Sep 30, 2020	0×
Jun 30, 2020	0.28×
Mar 31, 2020	0.625×
Dec 31, 2019	0×
Sep 30, 2019	7.375×
Jun 30, 2019	0×
Mar 31, 2019	0×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.